|
Code
|
68692
|
|
MA number
|
EU/1/05/319/005
|
|
Product Form:
|
sol iru 1x0,5 ml/75 mg (striek.inj.napl.skl. + ihla 26 pr.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Novartis Europharm Limited, Ireland
|
|
Therapeutic Class:
|
14 - BRONCHODILATANTIA, ANTIASTHMATICA
|
|
ATC:
|
| R |
RESPIRATORY SYSTEM |
| R03 |
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03D |
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03DX |
Other systemic drugs for obstructive airway diseases |
| R03DX05 |
Omalizumab |
|
|
Shelf life:
|
18 |
|
Route of admin.:
|
Subcutaneous use
|
European Medicines Agency's database
